TRICLIP™

TriClip™ TEER System

• TriClip™ is a first-of-its-kind, minimally invasive clip-based device that is specifically designed for the tricuspid valve, which is often referred to as the “forgotten valve” due to historically limited treatment options. It's a therapy for patients with a leaky tricuspid valve, a condition known as tricuspid regurgitation (TR).
• TriClip is a non-surgical option that provides a sustained reduction of TR with significant improvement in clinical outcomes and proven safety for patients who often aren't responding to medical therapy and are not surgical candidates.
• The device is delivered to the heart through the femoral vein in the leg and works by clipping together a portion of the leaflets of the tricuspid valve to reduce the backflow of blood.
• TriClip leverages the technology and robust body of evidence from Abbott’s leading MitraClip device – the safe, effective and minimally invasive option to repair leaky mitral valves (or mitral regurgitation), which occurs on the left/opposite side of the heart.
• TriClip is specifically designed for the tricuspid valve’s complex anatomy and has a specialized delivery system engineered for navigating the right side of the heart.

Tricuspid Regurgitation  

• Tricuspid regurgitation (TR) is a condition in which the valve between the two right heart chambers (right ventricle and right atrium) doesn’t close properly, resulting in a backward flow of blood into the right atrium of the heart.
• The condition typically impacts older individuals who have multiple co-morbidities, making open-heart surgery a high-risk procedure and resulting in many people going undertreated.
• The consequences of leaving TR unaddressed can be substantial – people often develop other conditions such as atrial fibrillation, and heart failure that can, ultimately, result in death.
• In general, the condition has been underdiagnosed and undertreated due to the disease being clinically underestimated.